 |
|
Adenosine and Its Agonists Cause Retinal Vasodilation and HemorrhagesImplications for Ischemic Retinopathies
Peter A. Campochiaro, MD;
Harsha A. Sen, MD
Arch Ophthalmol. 1989;107(3):412-416.
Abstract
• Animals were given a 0.1-mL intravitreous injection of various agents and followed up with frequent ophthalmoscopic examinations. Fundus photographs were performed before injection and at six and 24 hours after injection. Vascular caliber was assessed by a previously described technique of performing measurements on fundus photographs taken and projected in a standardized fashion. No significant vascular dilation was identified for vehicle alone, carbachol, histamine, isoproterenol hydrochloride, or bradykinin. Mild dilation within one hour, but not persisting for 24 hours, was noted for dibutyryl cyclic adenosine monophosphate. Prominent dilation within one hour, becoming maximal by five hours but not persisting for 24 hours, was noted for adenosine, dipyridamole, and sodium nitroprusside. The adenosine-induced vasodilation was effectively blocked by an adenosine receptor antagonist, BW-A1433U. N-ethylcarboxamidoadenosine (NECA), a nonspecific adenosine selective agonist, was a much more potent vasodilator than two relatively selective A1 adenosine agonists, N6-cyclopentyladenosine and N6-phenylisopropyladenosine, suggesting that A2 receptors are involved. The vascular dilation caused by adenosine, dipyridamole, and particularly NECA, but not nitroprusside or dibutyryl cyclic adenosine monophosphate, was accompanied by retinal hemorrhages, producing a picture reminiscent of some features of ischemic retinopathies. This study suggests that adenosine may be an important mediator of vasodilation, and therefore blood flow, in the retina.
Author Affiliations
From the Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville.
Footnotes
Accepted for publication Oct 3, 1988.
Reprint requests to Department of Ophthalmology, University of Virginia School of Medicine, Box 475, Charlottesville, VA 22908 (Dr Campochiaro).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Role of Adenosine in the Control of Choroidal Blood Flow during Changes in Ocular Perfusion Pressure
Schmidl et al.
IOVS 2011;52:6035-6039.
ABSTRACT
| FULL TEXT
Divergent Roles of Nitric Oxide and Rho Kinase in Vasomotor Regulation of Human Retinal Arterioles
Hein et al.
IOVS 2010;51:1583-1590.
ABSTRACT
| FULL TEXT
Oxygen Saturation in Human Retinal Vessels Is Higher in Dark Than in Light
Hardarson et al.
IOVS 2009;50:2308-2311.
ABSTRACT
| FULL TEXT
Adenosine A2A receptor mediated protective effect of 2-(6-cyano-1-hexyn-1-yl)adenosine on retinal ischaemia/reperfusion damage in rats
Konno et al.
Br J Ophthalmol 2006;90:900-905.
ABSTRACT
| FULL TEXT
Selective Upregulation of the A3 Adenosine Receptor in Eyes with Pseudoexfoliation Syndrome and Glaucoma
Schlotzer-Schrehardt et al.
IOVS 2005;46:2023-2034.
ABSTRACT
| FULL TEXT
Requisite Roles of A2A Receptors, Nitric Oxide, and KATP Channels in Retinal Arteriolar Dilation in Response to Adenosine
Hein et al.
IOVS 2005;46:2113-2119.
ABSTRACT
| FULL TEXT
Effects of Adenosine on Intraocular Pressure, Optic Nerve Head Blood Flow, and Choroidal Blood Flow in Healthy Humans
Polska et al.
IOVS 2003;44:3110-3114.
ABSTRACT
| FULL TEXT
Localization of Adenosine A2a Receptor in Retinal Development and Oxygen-Induced Retinopathy
Taomoto et al.
IOVS 2000;41:230-243.
ABSTRACT
| FULL TEXT
Intravitreous Injection of Adenosine or Its Agonists Causes Breakdown of the Blood-Retinal Barrier
Sen and Campochiaro
Arch Ophthalmol 1989;107:1364-1367.
ABSTRACT
|
